These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 16912549)

  • 21. Endothelial dysfunction as an early sign of atherosclerosis.
    Giannotti G; Landmesser U
    Herz; 2007 Oct; 32(7):568-72. PubMed ID: 17972030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Where the immune response meets the vessel wall.
    Bisoendial RJ; Stroes ES; Tak PP
    Neth J Med; 2009 Sep; 67(8):328-33. PubMed ID: 19767659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease?
    Sattar N
    Clin Sci (Lond); 2004 May; 106(5):443-5. PubMed ID: 14741042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation may be a bridge connecting hypertension and atherosclerosis.
    Li JJ; Chen JL
    Med Hypotheses; 2005; 64(5):925-9. PubMed ID: 15780486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Atherosclerosis: a chronic inflammatory diseases].
    Zapolska-Downar D; Zapolski-Downar A
    Przegl Lek; 2002; 59(3):147-52. PubMed ID: 12184027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function.
    Schiano V; Laurenzano E; Brevetti G; De Maio JI; Lanero S; Scopacasa F; Chiariello M
    Clin Nutr; 2008 Apr; 27(2):241-7. PubMed ID: 18237823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endothelium and inflammation.
    Trepels T; Zeiher AM; Fichtlscherer S
    Endothelium; 2006; 13(6):423-9. PubMed ID: 17169774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
    Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
    Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part II].
    Rajtar R; Kloch M; Bober M; Kolasińska-Kloch W
    Przegl Lek; 2006; 63(9):767-72. PubMed ID: 17479867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of soluble markers with various stages and major events of atherosclerosis.
    Wu JT; Wu LL
    Ann Clin Lab Sci; 2005; 35(3):240-50. PubMed ID: 16081579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction.
    Foster W; Shantsila E; Carruthers D; Lip GY; Blann AD
    Rheumatology (Oxford); 2009 Mar; 48(3):285-8. PubMed ID: 19153145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation.
    Ferri N; Paoletti R; Corsini A
    Curr Opin Lipidol; 2006 Oct; 17(5):495-501. PubMed ID: 16960497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial injury in the initiation and progression of vascular disorders.
    Tesfamariam B; DeFelice AF
    Vascul Pharmacol; 2007 Apr; 46(4):229-37. PubMed ID: 17218160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial function in familial combined hyperlipidaemia.
    Ter Avest E; Holewijn S; van Tits LJ; de Wit HM; Stalenhoef AF; de Graaf J
    Eur J Clin Invest; 2007 May; 37(5):381-9. PubMed ID: 17461984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk assessment in the patient with established peripheral arterial disease.
    Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folic acid, inflammation, and atherosclerosis: false hopes or the need for better trials?
    Mangoni AA
    Clin Chim Acta; 2006 May; 367(1-2):11-9. PubMed ID: 16413521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.
    Montecucco F; Mach F
    Rheumatology (Oxford); 2009 Jan; 48(1):11-22. PubMed ID: 18927189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of chronic inflammation in cardiovascular disease and its regulation by nutrients.
    Osiecki H
    Altern Med Rev; 2004 Mar; 9(1):32-53. PubMed ID: 15005643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying the vulnerable patient with rupture-prone plaque.
    Weintraub HS
    Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.